JP7671738B2 - Jak1阻害剤として有用な置換(7h-ピロロ[2,3-d]ピリミジン-4-イル)アミノ化合物 - Google Patents

Jak1阻害剤として有用な置換(7h-ピロロ[2,3-d]ピリミジン-4-イル)アミノ化合物 Download PDF

Info

Publication number
JP7671738B2
JP7671738B2 JP2022513571A JP2022513571A JP7671738B2 JP 7671738 B2 JP7671738 B2 JP 7671738B2 JP 2022513571 A JP2022513571 A JP 2022513571A JP 2022513571 A JP2022513571 A JP 2022513571A JP 7671738 B2 JP7671738 B2 JP 7671738B2
Authority
JP
Japan
Prior art keywords
compound
alkyl
pharmaceutical composition
formula
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022513571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545836A5 (https=
JPWO2021041392A5 (https=
JP2022545836A (ja
Inventor
スー,シーピン
シー リアン,シドニー
ジェイ ワース,ピーター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemwerth Inc
Original Assignee
Chemwerth Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemwerth Inc filed Critical Chemwerth Inc
Publication of JP2022545836A publication Critical patent/JP2022545836A/ja
Publication of JP2022545836A5 publication Critical patent/JP2022545836A5/ja
Publication of JPWO2021041392A5 publication Critical patent/JPWO2021041392A5/ja
Application granted granted Critical
Publication of JP7671738B2 publication Critical patent/JP7671738B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2022513571A 2019-08-26 2020-08-25 Jak1阻害剤として有用な置換(7h-ピロロ[2,3-d]ピリミジン-4-イル)アミノ化合物 Active JP7671738B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962891706P 2019-08-26 2019-08-26
US62/891,706 2019-08-26
PCT/US2020/047767 WO2021041392A1 (en) 2019-08-26 2020-08-25 Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino compounds useful as jak1 inhibitors

Publications (4)

Publication Number Publication Date
JP2022545836A JP2022545836A (ja) 2022-10-31
JP2022545836A5 JP2022545836A5 (https=) 2023-09-06
JPWO2021041392A5 JPWO2021041392A5 (https=) 2023-09-06
JP7671738B2 true JP7671738B2 (ja) 2025-05-02

Family

ID=74685810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513571A Active JP7671738B2 (ja) 2019-08-26 2020-08-25 Jak1阻害剤として有用な置換(7h-ピロロ[2,3-d]ピリミジン-4-イル)アミノ化合物

Country Status (9)

Country Link
US (1) US12492204B2 (https=)
EP (1) EP4021452B1 (https=)
JP (1) JP7671738B2 (https=)
CN (1) CN114761011B (https=)
AU (1) AU2020338043B2 (https=)
CA (1) CA3152021A1 (https=)
ES (1) ES2974946T3 (https=)
PL (1) PL4021452T3 (https=)
WO (1) WO2021041392A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020338043B2 (en) * 2019-08-26 2025-12-18 Chemwerth, Inc. Substituted (7H-pyrrolo[2,3-D]pyrimidin-4-yl)amino compounds useful as JAK1 inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013508266A (ja) 2009-10-15 2013-03-07 ファイザー・インク ピロロ[2,3−d]ピリミジン化合物
JP2015500845A (ja) 2011-12-21 2015-01-08 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途
JP2019505547A (ja) 2016-02-16 2019-02-28 ゾエティス・サービシーズ・エルエルシー 7H−ピロロ[2,3−d]ピリミジン化合物の調製方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101667822B1 (ko) * 2008-04-30 2016-10-19 내셔날 헬스 리서치 인스티튜트 오로라 키나아제 저해제용 접합 2고리 피리미딘 화합물
JP6944496B2 (ja) 2018-10-22 2021-10-06 ファイザー・インク ピロロ[2,3−d]ピリミジントシル酸塩、その結晶形態、ならびにその製造方法および中間体
AU2020338043B2 (en) * 2019-08-26 2025-12-18 Chemwerth, Inc. Substituted (7H-pyrrolo[2,3-D]pyrimidin-4-yl)amino compounds useful as JAK1 inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013508266A (ja) 2009-10-15 2013-03-07 ファイザー・インク ピロロ[2,3−d]ピリミジン化合物
JP2015500845A (ja) 2011-12-21 2015-01-08 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途
JP2019505547A (ja) 2016-02-16 2019-02-28 ゾエティス・サービシーズ・エルエルシー 7H−ピロロ[2,3−d]ピリミジン化合物の調製方法

Also Published As

Publication number Publication date
PL4021452T3 (pl) 2024-05-06
AU2020338043A1 (en) 2022-03-31
US20220274992A1 (en) 2022-09-01
US12492204B2 (en) 2025-12-09
AU2020338043B2 (en) 2025-12-18
WO2021041392A1 (en) 2021-03-04
JP2022545836A (ja) 2022-10-31
ES2974946T3 (es) 2024-07-02
CN114761011A (zh) 2022-07-15
EP4021452A1 (en) 2022-07-06
CN114761011B (zh) 2024-06-14
CA3152021A1 (en) 2021-03-04
EP4021452A4 (en) 2023-01-04
EP4021452B1 (en) 2023-12-20

Similar Documents

Publication Publication Date Title
US10980815B2 (en) Aminopyrimidinyl compounds
US12398141B2 (en) JAK kinase inhibitor, preparation method for same, and applications thereof in field of medicine
US8372854B2 (en) Pyrrolo[2,3-D]pyrimidine compounds
CA2900703C (en) Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of janus- related kinases (jak)
JP2023508772A (ja) Jak阻害剤化合物及びその使用
CN109790158B (zh) 作为jak抑制剂杂环化合物,该化合物的盐类及其治疗用途
JP7101685B2 (ja) 新規jakキナーゼ阻害剤としての二環式アミン
JP2025501553A (ja) 二環式インダゾールグルココルチコイド受容体拮抗薬
CA3015166A1 (en) 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
JP7671738B2 (ja) Jak1阻害剤として有用な置換(7h-ピロロ[2,3-d]ピリミジン-4-イル)アミノ化合物
EP3576743B1 (en) 5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2 5]octane-8-carboxylic acid derivatives as jak kinase inhibitors
JP7813290B2 (ja) Tyk2阻害剤
HK40077311A (en) Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino compounds useful as jak1 inhibitors
HK40077311B (en) Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino compounds useful as jak1 inhibitors
CN116063325A (zh) 具有btk调节作用的大环化合物及其用途
EA047455B1 (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-а]ПИРИДИНИЛА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ
HK40004455B (en) Heterocyclic compound as jak inhibitor, and salts and therapeutic use thereof
HK40004455A (en) Heterocyclic compound as jak inhibitor, and salts and therapeutic use thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230824

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230824

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230829

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250206

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250319

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250421

R150 Certificate of patent or registration of utility model

Ref document number: 7671738

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150